Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 2, 2012, Pages 240-250

  Mitra, Soma ^a   Barman, Soumik ^a   Nag, Dhrubajyoti ^a   Sinha, Ritam ^a   Saha, Dhira Rani ^a   Koley, Hemanta ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Mouse model; Oral immunization; Outer membrane vesicle; Passive immunity; Protective efficacy; Shigella sp

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; OUTER MEMBRANE VESICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE VESICLE; MOUSE; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROGENY; PUP (RODENT); SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; DYSENTERY, BACILLARY; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION, PASSIVE; MALE; MICE; SECRETORY VESICLES; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SURVIVAL ANALYSIS;

EID: 84867859543     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.01004.x     Document Type: Article

References (52)

1. Alaniz RC, Deatherage BL, Lara JC & Cookson BT (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 179: 7692-7701.
2. Balsalobre C, Silvan JM, Berglund S, Mizunoe Y, Uhlin BE & Wai SN (2006) Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Mol Microbiol 59: 99-112.
3. Bauman SJ & Kuehn MJ (2006) Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect 8: 2400-2408.
4. Boschi-Pinto C, Velebit L & Shibuya K (2008) Estimating child mortality due to diarrhoea in developing countries. Bull World Health Org 86: 710-717.
5. Cohen D, Ashkenazi S, Green MS et al. (1997) Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349: 155-159.
6. Coster TS, Hoge CW, Van De Verg LL et al. (1999) Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect Immun 67: 3437-3443.
7. Dalseg R, Wedege E, Holst J, Haugen IL, Høiby EA & Haneberg B (1999) Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine 17: 2336-2345.
8. Faruque SM, Khan R, Kamruzzaman M, Yamasaki S, Ahmad QS, Azim T, Nair GB, Takeda Y & Sack DA (2002) Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains. Appl Environ Microbiol 68: 3908-3913.
9. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A & Sansonetti PJ (2003) A newborn mouse model for the study of intestinal pathogenesis of Shigellosis. Cell Microbiol 5: 481-491.
10. Haneberg B, Dalseg R, Wedege E et al. (1998) Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun 66: 1334-1341.
11. Hayat MA & Miller SE, eds (1990) Negative Staining, pp. 36-48. McGraw-Hill, New York.
12. Hoge CW, Gambel JM, Srijan A, Pitarangsi C & Echeverria P (1998) Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 26: 341-345.
13. Horstman AL & Kuehn MJ (2000) Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J Biol Chem 275: 12489-12496.
14. Kadurugamuwa JL & Beveridge TJ (1998) Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles. Antimicrob Agents Chemother 42: 1476-1483.
15. Keenan J, Day T, Neal S, Cook B, Perez-Perez G, Allardyce R & Bagshaw P (2000) A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol Lett 182: 259-264.
16. Keren DF (1979) Enzyme-linked immunosorbent assay for immunoglobulin G and immunoglobulin A antibodies to Shigella flexneri antigens. Infect Immun 24: 441-448.
17. Kesavalu L, Ebersole JL, Machen RL & Holt SC (1992) Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 60: 1455-1464.
18. Koley H, Ghosh AN, Paul M, Ghosh AR, Ganguly PK & Nair GB (1995) Colonization ability & intestinal pathology of rabbits orally fed with Vibrio cholerae O139 Bengal. Indian J Med Res 101: 57-61.
19. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK & Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Org 77: 651-666.
20. Kuehn MJ & Kesty NC (2005) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19: 2645-2655.
21. Kweon MN (2008) Shigellosis: the current status of vaccine development. Curr Opin Infect Dis 21: 313-318.
22. Lee EY, Choi DS, Kim KP & Gho YS (2008) Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev 27: 535-555.
23. Levenson VI, Egorova TP, Belkin ZP, Fedosova VG, Subbotina JL, Rukhadze EZ, Dzhikidze EK & Stassilevich ZK (1991) Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun 59: 3610-3618.
24. Levine MM, Kotloff KL, Barry EM, Pasetti MF & Sztein MB (2007) Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5: 540-553.
25. Li A, Rong ZC, Ekwall E, Forsum U & Lindberg AA (1993) Serum antibody responses against Shigella lipopolysaccharides and invasion plasmid-coded antigens in Shigella infected Swedish patients. Scand J Infect Dis 25: 569-577.
26. Nevot M, Deroncelé V, Messner P, Guinea J & Mercadé E (2006) Characterization of outer membrane vesicles released by the psychrotolerant bacterium Pseudoalteromonas antarctica NF3. Environ Microbiol 8: 1523-1533.
27. Nicolas B, Razack BA, Yollande I, Aly S, Tidiane OCA, Philippe NA, De Souza C & Sababénédjo TA (2007) Street-vended foods improvement: contamination mechanisms and application of Food Safety Objective Strategy: Critical Review. Pak J Nutr 6: 1-10.
28. Niyogi SK (2007) Increasing antimicrobial resistance-an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 13: 1141-1143.
29. Noriega FR, Wang JY, Losonsky G, Maneval DR, Hone DM & Levine MM (1994) Construction and characterization of attenuated DaroA DvirG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun 62: 5168-5172.
30. Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB & Levine MM (1999) Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun 67: 782-788.
31. Oaks EV, Hale TL & Formal SB (1986) Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun 53: 57-63.
32. Orr N, Robin G, Cohen D, Arnon R & Lowell GH (1993) Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect Immun 61: 2390-2395.
33. Perdomo JJ, Gounon P & Sansonetti PJ (1994a) Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest 93: 633-643.
34. Perdomo OJJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P & Sansonetti PJ (1994b) Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med 180: 1307-1319.
35. Phalipon A & Sansonetti PJ (2007) Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 85: 119-129.
36. Phalipon A, Kaufmann M, Michetti P, Cavaillon JM, Huerre M, Sansonetti PJ, Kraehenbuhi JP (1995) Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med 182: 769-778.
37. Roy N, Barman S, Ghosh A, Pal A, Chakraborty K, Das SS, Saha DR, Yamasaki S & Koley H (2010) Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model. FEMS Immunol Med Microbiol 60: 18-27.
38. Samandari T, Kotloff KL, Losonsky GA, Picking WD, Sansonetti PJ, Levine MM & Sztein MB (2000) Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain. J Immunol 164: 2221-2232.
39. Sansonetti PJ, Arondel J, Fontaine A, d'Hauteville H & Bernardini ML (1991) OmpB (osmo-regulation) and icsA (cell to cell spread) mutants of Shigella flexneri. Evaluation as vaccine candidates. Probes to study the pathogenesis of shigellosis. Vaccine 9: 416-422.
40. Sansonetti PJ, Tran Van Nhieu G & Egile C (1999) Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin Infect Dis 28: 466-475.
41. Sasakawa C, Buysse JM & Watanabe H (1992) The large virulence plasmid of Shigella. Curr Top Microbiol Immunol 180: 21-44.
42. Sasakawa C, Komatsu K, Tobe T, Suzuki T & Yoshikawa M (1993) Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by Shigella flexneri 2a. J Bacteriol 175: 2324-2346.
43. Saunders NB, Shoemaker DR, Brandt BL, Moran EE, Larsen T & Zollinger WD (1999) Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun 67: 113-119.
44. Schild S, Nelson EJ & Camilli A (2008) Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 76: 4554-4563.
45. Schild S, Nelson EJ, Bishop AL & Camilli A (2009) Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77: 472-484.
46. Sur D, Ramamurthy T, Deen J & Bhattacharya SK (2004) Shigellosis: challenges and management issues. Indian J Med Res 120: 454-462.
47. Vargas M, Gascon J, De Jimenez Anta MT & Vila J (1999) Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol 37: 3608-3611.
48. Venkatesan MM & Ranallo RT (2006) Live-attenuated Shigella vaccines. Expert Rev Vaccines 5: 669-686.
49. Van de Verg LL, Mallett CP, Collins HH, Larsen T, Hammack C & Hale TL (1995) Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect Immun 63: 1947-1954.
50. Vidal M, Kruger E, Durán C, Lagos R, Levine M, Prado V, Toro C & Vidal R (2005) Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections. J Clin Microbiol 43: 5362-5365.
51. Voino-Yasenetsky MV & Voino-Yasenetskaya MK (1961) Experimental pneumonia caused by bacteria of the Shigella group. Acta Morphol XI: 440-454.
52. Wai SN, Lindmark B, Söderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y & Uhlin BE (2003) Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115: 25-35.